268 related articles for article (PubMed ID: 549184)
1. Surface antigens as virulence factors in infection with Bacteroides fragilis.
Kasper DL; Onderdonk AB; Polk BF; Bartlett JG
Rev Infect Dis; 1979; 1(2):278-90. PubMed ID: 549184
[TBL] [Abstract][Full Text] [Related]
2. Infection with Bacteroides fragilis: pathogenesis and immunoprophylaxis in an animal model.
Kasper DL; Onderdonk AB
Scand J Infect Dis Suppl; 1982; 31():28-33. PubMed ID: 6954635
[TBL] [Abstract][Full Text] [Related]
3. The capsular polysaccharide of Bacteroides fragilis as a virulence factor: comparison of the pathogenic potential of encapsulated and unencapsulated strains.
Onderdonk AB; Kasper DL; Cisneros RL; Bartlett JG
J Infect Dis; 1977 Jul; 136(1):82-9. PubMed ID: 886206
[TBL] [Abstract][Full Text] [Related]
4. Pathogenicity of Bacteroides fragilis group in rat intra-abdominal abscesses.
Jotwani R; Gupta U; Watanabe K; Ueno K
Microbiol Immunol; 1992; 36(10):1041-9. PubMed ID: 1479960
[TBL] [Abstract][Full Text] [Related]
5. Encapsulation and protection against phagocytosis by Bacteroides fragilis.
Lindberg AA; Weintraub A
Scand J Infect Dis Suppl; 1985; 46():27-32. PubMed ID: 3865350
[TBL] [Abstract][Full Text] [Related]
6. Protective efficacy of immunization with capsular antigen against experimental infection with Bacteroides fragilis.
Kasper DL; Onderdonk AB; Crabb J; Bartlett JG
J Infect Dis; 1979 Nov; 140(5):724-31. PubMed ID: 528789
[TBL] [Abstract][Full Text] [Related]
7. The polysaccharide capsule of Bacteroides fragilis subspecies fragilis: immunochemical and morphologic definition.
Kasper DL
J Infect Dis; 1976 Jan; 133(1):79-87. PubMed ID: 1451
[TBL] [Abstract][Full Text] [Related]
8. Use of a model of intraabdominal sepsis for studies of the pathogenicity of Bacteroides fragilis.
Onderdonk AB; Shapiro ME; Finberg RW; Zaleznik DF; Kasper DL
Rev Infect Dis; 1984; 6 Suppl 1():S91-5. PubMed ID: 6372042
[TBL] [Abstract][Full Text] [Related]
9. Quantitative determination of the antibody response to the capsular polysaccharide of Bacteroides fragilis in an animal model of intraabdominal abscess formation.
Kasper DL; Onderdonk AB; Bartlett JG
J Infect Dis; 1977 Dec; 136(6):789-95. PubMed ID: 336801
[TBL] [Abstract][Full Text] [Related]
10. Effect of subinhibitory doses of clindamycin on the virulence of Bacteroides fragilis: role of lipopolysaccharide.
Zaleznik DF; Zhang ZL; Onderdonk AB; Kasper DL
J Infect Dis; 1986 Jul; 154(1):40-6. PubMed ID: 3711690
[TBL] [Abstract][Full Text] [Related]
11. Animal model system for studying virulence of and host response to Bacteroides fragilis.
Onderdonk AB; Cisneros RL; Finberg R; Crabb JH; Kasper DL
Rev Infect Dis; 1990; 12 Suppl 2():S169-77. PubMed ID: 2406869
[TBL] [Abstract][Full Text] [Related]
12. Immunochemical characterization of surface antigens of Bacteroides melaninogenicus.
Mansheim BJ; Onderdonk AB; Kasper DL
Rev Infect Dis; 1979; 1(2):263-77. PubMed ID: 44922
[TBL] [Abstract][Full Text] [Related]
13. Virulence factors in Bacteroides fragilis group.
Jotwani R; Gupta U
Indian J Med Res; 1991 Jul; 93():232-5. PubMed ID: 1959952
[TBL] [Abstract][Full Text] [Related]
14. Evidence for T cell-dependent immunity to Bacteroides fragilis in an intraabdominal abscess model.
Onderdonk AB; Markham RB; Zaleznik DF; Cisneros RL; Kasper DL
J Clin Invest; 1982 Jan; 69(1):9-16. PubMed ID: 6976357
[TBL] [Abstract][Full Text] [Related]
15. Cellular immunity to Bacteroides fragilis capsular polysaccharide.
Shapiro ME; Onderdonk AB; Kasper DL; Finberg RW
J Exp Med; 1982 Apr; 155(4):1188-97. PubMed ID: 6174672
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibodies to detect capsular diversity among Bacteroides fragilis isolates.
Pantosti A; Colangeli R; Tzianabos AO; Kasper DL
J Clin Microbiol; 1995 Oct; 33(10):2647-52. PubMed ID: 8567899
[TBL] [Abstract][Full Text] [Related]
17. Immunochemistry of the surface carbohydrate antigens of Bacteroides fragilis and definition of a common antigen.
Poxton IR; Brown R
J Gen Microbiol; 1986 Sep; 132(9):2475-81. PubMed ID: 2432160
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the common immunodominant antigenic determinant in the lipopolysaccharide of Bacteroides fragilis by a monoclonal antibody.
Linko L; Weintraub A; Arstila P; Pelliniemi LJ; Viljanen MK
Scand J Immunol; 1987 May; 25(5):469-75. PubMed ID: 2438749
[TBL] [Abstract][Full Text] [Related]
19. Immunological detection of Bacteroides fragilis in clinical samples.
Patrick S; Stewart LD; Damani N; Wilson KG; Lutton DA; Larkin MJ; Poxton I; Brown R
J Med Microbiol; 1995 Aug; 43(2):99-109. PubMed ID: 7629860
[TBL] [Abstract][Full Text] [Related]
20. Pathogenicity of the Bacteroides fragilis group.
Brook I
Ann Clin Lab Sci; 1989; 19(5):360-76. PubMed ID: 2679351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
